What Has Been the Growth Trajectory of the Preclinical CRO Market?
The preclinical cro market has seen considerable growth due to a variety of factors.
•The preclinical CRO market has experienced significant expansion in the past few years. The market size is projected to escalate from $5.7 billion in 2024 to $6.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.9%.
The notable growth during the historical period is linked to the rising demand for rapid drug development, strategies to contain costs, concentration on fundamental competencies, requirements for regulatory compliance, and the worldwide expansion of clinical trials.
What Does the Future Hold for the Preclinical CRO Market?
The preclinical cro market is expected to maintain its strong growth trajectory in upcoming years.
• In the years to come, the preclinical CRO market is projected to experience solid growth, reaching a market size of "$9.06 billion by 2029. This represents a compound annual growth rate (CAGR) of 9.7%.
Factors contributing to the growth during this forecast period include an uptick in personalized medicine, attention to rare diseases and orphan drugs, a rise in biopharmaceutical outsourcing, increased biomarker research, and a need for real-world evidence generation. The forecast period will also witness trends such as the application of artificial intelligence (AI), the spread of oncology research, progress in omics technologies, enhancements in vitro and in vivo models, and cooperative efforts in translational research.
What Are the Critical Driver Fuelling the Preclinical CRO Market's Growth?
The growth of the preclinical CRO market is anticipated to be driven by the rising demand for preclinical trials. These trials, which involve the study of a medical treatment or drug prior to its testing on human subjects, are gaining prominence as the industry places greater emphasis on the safety and efficacy of new medications. Preclinical studies commonly deal with innovative medical devices, prescription drugs, and diagnostics, and their main aim is to identify a safe starting dosage for first-time human research while also assessing potential product toxicity. Preclinical trials are integral to the process of drug development, a fact underscored by IQVIA, a US-based firm that specializes in health information technology and clinical research. The company reported in February 2024 that the year 2023 witnessed an increase in clinical development productivity, with 69 new active substances (NASs) launched worldwide, six more than the previous year, and 24 first-in-class introductions in the U.S specifically. Consequently, the rising need for preclinical trials is driving the preclinical CRO market's growth.
How Is the Preclinical CRO Market segmented?
The preclinical CRO market covered in this report is segmented –
1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users
Subsegments:
1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing
3) By Compound Management: Sample Management, Inventory Management, Formulation Services
4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies
6) By Other Services: Regulatory Consulting, Project Management, Data Management Services
Pre-Book The Preclinical CRO Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Preclinical CRO Market?
The uptake of new technologies is a significant trend making waves in the preclinical CRO market. Top players in this sector are leveraging innovative solutions to maintain their market stronghold. A notable example is BenchSci, a Canada-based AI solutions provider for preclinical R&D. In February 2023, the company introduced ASCEND, a comprehensive SaaS (software as a service) platform designed for preclinical drug discovery. This approach aims to expedite the preclinical drug development process by increasing our understanding of the fundamental biology of diseases. With the aid of BenchSci's machine-learning technology, ASCEND retrieves experimental data from secure in-house and public resources. The platform makes a comparison of experimental outcomes using curated ontology datasets. Consequently, the software can generate a map of the biological mechanisms underlying various diseases, supported by evidence.
Who Are the Key Players in the Preclinical CRO Market?
Major companies operating in the preclinical CRO market include:
• Eurofins Scientific SE
• PRA Health Sciences Inc.
• Wuxi AppTec Co. Ltd.
• Medpace Holdings Inc.
• Charles River Laboratories International Inc.
• Laboratory Corporation of America Holdings
• SGA SA
• Intertek Group plc
• Crown Bioscience International
• Cynbiose
• AmplifyBio LLC
• Vivotecnia SL
• Simavita Ltd.
• BioEmission Technology Solutions
• Altasciences Company Inc.
• Global Center For Medical Innovation
• Pharmaceutical Product Development LLC
• Parexel International Corporation
• Envigo RMS Holding Corporation
• Veeda Clinical Research Ltd.
• ICON plc
• Kunming Biomed International Ltd.
• PharmaLegacy Laboratories
• NorthEast BioAnalytical Laboratories LLC
• MDS Pharma Services
• MPI Research
• Toxikon Corporation
• BioReliance Corporation
• Covance Inc.
• Syngene International Limited
What Is The Most Dominant Region In The Preclinical CRO Market?
North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
